Elsevier

The Annals of Thoracic Surgery

Volume 60, Issue 6, December 1995, Pages 1854-1855
The Annals of Thoracic Surgery

Update
Tracheal sleeve pneumonectomy for brochogenic carcinoma: Report of 55 cases

https://doi.org/10.1016/0003-4975(95)00506-4Get rights and content

Abstract

From 1966 to 1986, a total of 55 patients underwent a tracheal sleeve pneumonectomy (53 right and 2 left) for bronchogenic carcinoma. Preoperative radiotherapy was given in only 5 patients. The overall operative death rate was 10.9%, but no patient has died since 1975 (32 survivors). Seven patients had a postoperative empyema (12.7%); 4 of these patients had a bronchopleural fistula. Twenty-five patients had postoperative radiotherapy, 5 of whom also had chemotherapy. The actuarial survival rate, after exclusion of the 6 operative deaths, was 38% at 3 years and 23% at 5 years. Survival was correlated to regional lymph node involvement. The actuarial survival rate among patients with tumoral spread to bronchial lymph nodes was 43% at 3 years. Among the 13 patients with only subcarinal involvement, the actuarial survival rate was 34% at 3 years. None of the 8 patients with paratracheal lymph node involvement survived more than 30 months.

These results indicate that tracheal sleeve penumonectomy for bronchoigenic carcinoma with extention to the carina is now fully justified considering the low operative mortality and the good results observed when lateral tracheal lymph nodes were not involved.

References (4)

There are more references available in the full text version of this article.

Cited by (35)

  • Carinal surgery: A single-institution experience spanning 2 decades

    2019, Journal of Thoracic and Cardiovascular Surgery
  • Early and Long-Term Results of Tracheal Sleeve Pneumonectomy for Lung Cancer After Induction Therapy

    2018, Annals of Thoracic Surgery
    Citation Excerpt :

    However, refinements in surgical techniques, indications, and intraoperative and postoperative management have led to recent series showing good results in tracheobronchial resection and reconstruction [1–4, 8, 9, 11–16], demonstrating that this type of surgery is safe and can lead to acceptable long-term results. Indeed, highly experienced centers reported a 5-year overall survival ranging from 25.5% to 44% [9, 11–13, 15, 17, 18]. Our series is in line with the literature with an overall 5-year survival rate of 30.3%.

  • Carinal resection and sleeve pneumonectomy

    2014, Thoracic Surgery Clinics
    Citation Excerpt :

    The reported mortality rates following SP ranges from 2% to 20 % (Table 1). In the series reported after 2005, the mortality rate ranges from 2% to 8.5%.1,10,13,22,25,27–29 In the authors’ center between 2001 and 2010, 12 right and 2 left SPs were performed.

  • Sleeve pneumonectomy for central non-small cell lung cancer: Indications, complications, and survival

    2013, Annals of Thoracic Surgery
    Citation Excerpt :

    Poor survival for progressive nodal affection has also been observed in our series with 5-year survival rates of 70%, 35%, and 9% for pN0, pN1, and pN2, respectively (Table 4). Regarding preoperatively proven N2 as a contraindication for extensive surgery, most authors claim for routine invasive mediastinal staging in all lung cancer patients [3, 5, 7, 14]. We did not routinely perform mediastinoscopy but explored the mediastinal space using EBUS-TBNA.

View all citing articles on Scopus
View full text